Form 4 for CVS CVS Health
Accepted 2024-09-03 00:00:00 ET · period of report 2024-08-31 · accession 0001127602-24-023352 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-03 | 2024-08-31 | CVS | Mandadi Tilak | EVP, CTO | F - Tax | $57.24 | -13.1K | 40.4K | -24% | -$749.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-31 | F | D | 13,097 | $57.24 | 40,414 | D | — | — | (F1) Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. |